Phreesia (NYSE:PHR) Receives Outperform Rating from Royal Bank Of Canada

Key Points

• Royal Bank of Canada reiterated its “outperform” rating on Phreesia and set a $19 price target, implying approximately 70% upside from the prior close.
• Analyst sentiment is mixed overall: nine analysts rate the stock a Buy, nine a Hold and one a Sell, resulting in a consensus Hold rating and an average price target of $16.29.
• Phreesia’s latest quarter included revenue of $129.46 million, slightly above expectations, but earnings per share of $0.03 missed the $0.09 consensus estimate. Institutional investors own 92.1% of the company’s shares.

Phreesia (NYSE:PHR - Get Free Report)'s stock had its "outperform" rating reiterated by equities researchers at Royal Bank Of Canada in a research report issued on Thursday, Benzinga reports. They presently have a $19.00 target price on the stock. Royal Bank Of Canada's price target indicates a potential upside of 70.11% from the stock's previous close.

Several other equities research analysts have also recently weighed in on the stock. DA Davidson reaffirmed a "buy" rating and set a $14.00 price objective on shares of Phreesia in a research report on Thursday, May 28th. Piper Sandler cut shares of Phreesia from an "overweight" rating to a "neutral" rating and set a $12.00 target price for the company. in a research report on Thursday, May 28th. Wells Fargo & Company set a $10.00 price target on shares of Phreesia and gave the stock an "equal weight" rating in a report on Thursday. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a research report on Saturday, May 30th. Finally, Truist Financial increased their price target on shares of Phreesia from $11.00 to $12.00 and gave the stock a "hold" rating in a research report on Thursday, May 28th. Nine equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $16.29.

Phreesia Price Performance

Phreesia stock traded down $0.68 during mid-day trading on Thursday, reaching $11.17. 168,073 shares of the company were exchanged, compared to its average volume of 1,492,030. The firm has a market cap of $690.36 million, a PE ratio of 74.30 and a beta of 0.86. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.76 and a quick ratio of 1.76. The company has a fifty day simple moving average of $11.19 and a 200-day simple moving average of $10.48. Phreesia has a 12 month low of $7.77 and a 12 month high of $31.38.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Wednesday, September 2nd. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.06). The company had revenue of $129.46 million for the quarter, compared to the consensus estimate of $129.06 million. Phreesia had a net margin of 1.85% and a return on equity of 5.13%. The business's revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.01 earnings per share. As a group, equities research analysts expect that Phreesia will post 0.39 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Royal Bank of Canada grew its holdings in shares of Phreesia by 208.8% during the 1st quarter. Royal Bank of Canada now owns 24,119 shares of the company's stock valued at $617,000 after purchasing an additional 16,309 shares during the last quarter. AQR Capital Management LLC boosted its position in Phreesia by 471.2% in the first quarter. AQR Capital Management LLC now owns 160,032 shares of the company's stock valued at $4,090,000 after buying an additional 132,015 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Phreesia by 3.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 62,557 shares of the company's stock worth $1,599,000 after buying an additional 2,158 shares during the last quarter. NewEdge Advisors LLC grew its stake in shares of Phreesia by 262.7% during the first quarter. NewEdge Advisors LLC now owns 15,437 shares of the company's stock worth $395,000 after buying an additional 11,181 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its holdings in shares of Phreesia by 0.4% during the first quarter. Goldman Sachs Group Inc. now owns 600,012 shares of the company's stock worth $15,336,000 after buying an additional 2,402 shares in the last quarter. Institutional investors own 92.10% of the company's stock.

Phreesia News Roundup

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Management maintained fiscal 2027 revenue guidance of $510 million to $520 million, broadly in line with Wall Street expectations, reducing the risk of a near-term outlook cut. Phreesia maintains FY2027 revenue outlook
• Positive Sentiment: Phreesia reported positive operating and free cash flow for the quarter and reduced debt principal by more than $23 million, supporting balance-sheet improvement and potentially lowering future interest costs. Phreesia Announces Second Quarter Fiscal 2027 Results
• Positive Sentiment: Management identified AccessOne as a multi-year growth opportunity, giving investors an additional potential driver beyond the company’s core revenue expansion. Needham & Company also initiated or reiterated a Buy rating, adding analyst support. Needham Buy Rating
• Neutral Sentiment: The quarter’s revenue growth and profitability expansion were described as in line with expectations, suggesting execution remains steady but did not produce a major upside surprise. Phreesia Q2 2027 Earnings Call Transcript
• Negative Sentiment: Adjusted earnings were materially below consensus at $0.03 per share versus the expected $0.09-$0.11. The miss may limit upside for PHR despite the revenue beat and maintained full-year outlook. Phreesia Q2 Earnings and Revenues Lag Estimates

About Phreesia

Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source